Skip to main content
Top

Endocrine Pathology

Issue 2/2005

Content (10 Articles)

Review

Cortical-chromaffin cell interactions in the adrenal gland

Sven Schinner, Stefan R. Bornstein

Clinical Research

BRAF copy number gains in thyroid tumors detected by fluorescence In Situ hybridization

Raffaele Ciampi, Zhaowen Zhu, Yuri E. Nikiforov

Clinical Research

Galectin-3 expression in functioning and silent ACTH-Producing adenomas

Long Jin, Dominik Riss, Katharina Ruebel, Sabine Kajita, Bernd W. Scheithauer, Eva Horvath, Kalman Kovacs, Ricardo V. Lloyd

Clinical Research

Expression of hypoxia-inducible factor 1α and cathepsin D in pituitary adenomas

Daizo Yoshida, Kyongsong Kim, Michio Yamazaki, Akira Teramoto

Clinical Research

The pituitary in klinefelter syndrome

B. W. Scheithauer, M. Moschopulos, K. Kovacs, B. S. Jhaveri, T. Percek, R. V. Lloyd

Letter

Metastasis of urothelial sarcomatoid carcinoma to a toxic multinodular goiter

G. Papi, S. Corrado, L. Scaltriti, C. Carapezzi, S. Ezzat

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine